Company Dynamic

Henkel and Sasol have entered into a strategic partnership to reduce the environmental impact of hot melt adhesives.

• Henkel
• Sasol

Sanofi is making a bold $470 million move to accelerate its presence in neurodegeneration by acquiring Vigil Neuroscience.

Sanofi has struck a $470 million deal to acquire Vigil Neuroscience, a bold move aimed at securing VG-3927, an investigational oral small molecule designed to target TREM2—a key immune receptor linked to Alzheimer’s disease.

AkzoNobel announced its intention to close production sites in Wappenfeld (Netherlands) and Mahelen (Belgium) and consolidate production at other sites in the region.

• AkzoNobel

German chemical and pharmaceutical conglomerate Bayer is facing escalating legal pressure in the United States over its controversial herbicide glyphosate, sold under the brand Roundup.

Lanxess has earned an “A” rating from CDP, a leading climate protection disclosure organization, placing it among the top 2% of over 24,700 companies worldwide.

On May 16, 2025, a major leap was made in China’s adhesive industry as Shandong ADINO New Materials Co., Ltd. held its grand opening in Tancheng County, Linyi.

In a surprising development on May 16, Novo Nordisk announced the impending departure of CEO Lars Fruergaard Jørgensen, who has led the company through a tripling of revenue, profit, and market value over the past 8 years.

On May 13, 2025, public records from Qichacha revealed that Roche Diagnostics Products (Shanghai) Co., Ltd. has been officially penalized for three serious breaches of China’s occupational health laws.

AkzoNobel’s Indian operations may soon change hands for a price between $1.17 billion and $1.4 billion, marking a pivotal step in the company’s strategy to refocus on its core coatings business and reallocate capital.

Novartis achieved a major regulatory milestone as asciminib tablets were officially approved by China’s NMPA for the treatment of newly diagnosed adult patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph+ CML-CP).

On May 22, Honeywell revealed a bold move: an all-cash acquisition worth £1.8 billion (approx. RMB 17.4 billion or USD 2.2 billion) to purchase Johnson Matthey’s Catalyst Technologies division.

In a move that could redefine India’s competitive paint landscape, JSW Group is on the verge of acquiring a 75% stake in Akzo Nobel India for ₹120 billion (approx. ¥101 billion).

Wanhua Chemical is set to halt production across multiple high-capacity units in June, as it initiates both scheduled maintenance and strategic upgrades.

Sun Pharmaceutical Industries Ltd has announced an increased investment in U.S.-based Pharmazz Inc., raising its total commitment to $25 million and expanding its ownership stake to 22.7%.

Sanofi, a leading French pharmaceutical giant, has announced its $470 million acquisition of Vigil Neuroscience, a clinical-stage biotech company, in an effort to strengthen its neurological drug development pipeline.

On May 14, Nippon Paint Holdings announced its 2025 Q1 financial results, reporting a 5.6 percent increase in sales to 405.72 billion yen ($2.68 billion), driven by higher volumes and the impact of recent acquisitions, including US-based AOC.

On May 14, AkzoNobel India announced its 2025 fiscal year results, achieving annual revenue of ₹40.91 billion ($477.4 million), a 3 percent year-on-year increase.

On May 15, Chinese battery giant CATL signed a landmark patent licensing agreement with MU Ionic Solutions Corporation (MUIS), a subsidiary of Mitsubishi Chemical, securing access to MUIS’s cutting-edge lithium-ion battery (LIB) technologies.

On May 15, Syensqo, a global leader in specialty materials, announced a Q1 2025 EBITDA of €311 million, reflecting an organic decline of 15%.